FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer
(MedPage Today) -- The FDA approved nogapendekin alfa inbakicept (Anktiva) for bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC), the agency announced Monday.
A first-in-class interleukin (IL)-15 receptor... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 23, 2024 Category: American Health Source Type: news
FDA Approves New Bladder Cancer Drug FDA Approves New Bladder Cancer Drug
The first-in-class agent is approved alongside bacillus Calmette-Gu érin to treat certain non–muscle-invasive bladder cancers that do not respond to bacillus Calmette-Guérin alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 23, 2024 Category: Science Authors: Times staff Source Type: news
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
On April 22, 2024, the Food and Drug Administration approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with Bacillus Calmette-Gu érin (BCG) for adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papilla (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 22, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CULVER CITY, Calif., April 22, 2024 -- ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 22, 2024 Category: Drugs & Pharmacology Source Type: news
Urine Test Could Cut Need for Painful Bladder Cancer Procedure
MONDAY, April 8, 2024 -- A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn ’t come back, researchers report.People who’ve gotten surgery for high-risk bladder cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Dr Google will see you now! Women diagnosed with ovarian cancer look up tell-tale symptoms of deadly disease a YEAR before being diagnosed
Women battling the disease looked up symptoms including weight loss , bladder problems and bloating up to 360 days before being referred to a specialist. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2024 Category: Consumer Health News Source Type: news
Drug Combo Marks Advance Against Bladder Cancer
MONDAY, March 11, 2024 -- A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 11, 2024 Category: General Medicine Source Type: news
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer
(MedPage Today) -- The FDA approved the PD-1 immune checkpoint inhibitor nivolumab (Opdivo) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, the agency announced... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
Dr Amir shares 11 warning signs of the 'least talked about' cancer
The TV doctor warns that symptoms of bladder cancer can be dismissed as something else, and urges everyone who experiences one tell-tale sign to get checked. (Source: Daily Express - Health)
Source: Daily Express - Health - February 14, 2024 Category: Consumer Health News Source Type: news
Defense Secretary Austin transfers powers to deputy while back in hospital
Defense Secretary Lloyd Austin was hospitalized again Sunday to address a bladder issue as he continues to recover from prostate cancer and has transferred authorities to his deputy, the Pentagon said. Austin was diagnosed with prostate cancer in December and continues to deal with complications…#defense #lloydaustin #pentagon #pentagonpress #patryder #defensekathleenhicks #walterreed #johnmaddox #gregorychesnut #austin (Source: Reuters: Health)
Source: Reuters: Health - February 12, 2024 Category: Consumer Health News Source Type: news
Defense Secretary Returns to Hospital With Bladder Issues
MONDAY, Feb. 12, 2024 (Healthday News) -- Defense Secretary Lloyd Austin III, who spent time in intensive care last month for complications related to prostate cancer surgery performed in December, has returned to the hospital with bladder issues,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2024 Category: General Medicine Source Type: news
Lloyd Austin hospitalized with " emergent bladder issue, " Pentagon says
Defense Secretary Lloyd Austin was hospitalized again on Sunday, this time "for symptoms suggesting an emergent bladder issue," the Pentagon announced. The big picture: Less than a month after he was released from the hospital following complications from a treatment for prostate cancer, Pentagon…#defense #lloydaustin #pentagon #patryder #ryder #jointchiefsofstaff #congressional (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2024 Category: Consumer Health News Source Type: news
Top Causes of Early Noncancer Deaths in Advanced GU Cancers Top Causes of Early Noncancer Deaths in Advanced GU Cancers
Sepsis was the leading reason for early noncancer deaths in patients with metastatic bladder, kidney, or prostate cancer, a recent analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
'I'm a doctor - here are four symptoms of bladder cancer to get checked out'
If you notice any of these worrying symptoms you should speak to your GP. (Source: Daily Express - Health)
Source: Daily Express - Health - February 1, 2024 Category: Consumer Health News Source Type: news
